Immediate Impact
50 standout
Citing Papers
Different Targeting Ligands-Mediated Drug Delivery Systems for Tumor Therapy
2024 Standout
CAR T Cells and T-Cell Therapies for Cancer
2024 Standout
Works of Andy Chen being referenced
Prolonged hematologic toxicity following treatment with chimeric antigen receptor T cells in patients with hematologic malignancies
2021
Phase I Study of the Anti-CD22 Antibody–Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Andy Chen | 201 | 111 | 33 | 57 | 20 | 257 | |
| Timothy Voorhees | 138 | 79 | 19 | 52 | 35 | 220 | |
| Elizabeth Budde | 154 | 61 | 36 | 101 | 26 | 266 | |
| Maria A. V. Marzolini | 217 | 83 | 15 | 67 | 19 | 294 | |
| Pashna N. Munshi | 195 | 103 | 41 | 80 | 24 | 303 | |
| Patrycja Wawrzyniecka | 228 | 85 | 14 | 72 | 16 | 291 | |
| Naseer Qayum | 225 | 162 | 47 | 87 | 21 | 332 | |
| Sandra P. Susanibar-Adaniya | 161 | 126 | 50 | 114 | 27 | 301 | |
| Yngvild Nuvin Blaker | 202 | 170 | 49 | 31 | 12 | 286 | |
| Dena DeMarco | 289 | 217 | 72 | 37 | 13 | 329 | |
| Nathan Denlinger | 187 | 52 | 25 | 72 | 30 | 301 |
All Works
Login with ORCID to disown or claim papers
Loading papers...